Anti-TEDC2 monoclonal antibody

Pre-made anti-TEDC2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TEDC2/TEDC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2767-Ab-1/ GM-Tg-hg-IP2767-Ab-2Anti-Human TEDC2 monoclonal antibodyHuman
GM-Tg-rg-IP2767-Ab-1/ GM-Tg-rg-IP2767-Ab-2Anti-Rat TEDC2 monoclonal antibodyRat
GM-Tg-mg-IP2767-Ab-1/ GM-Tg-mg-IP2767-Ab-2Anti-Mouse TEDC2 monoclonal antibodyMouse
GM-Tg-cynog-IP2767-Ab-1/ GM-Tg-cynog-IP2767-Ab-2Anti-Cynomolgus/ Rhesus macaque TEDC2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2767-Ab-1/ GM-Tg-felg-IP2767-Ab-2Anti-Feline TEDC2 monoclonal antibodyFeline
GM-Tg-cang-IP2767-Ab-1/ GM-Tg-cang-IP2767-Ab-2Anti-Canine TEDC2 monoclonal antibodyCanine
GM-Tg-bovg-IP2767-Ab-1/ GM-Tg-bovg-IP2767-Ab-2Anti-Bovine TEDC2 monoclonal antibodyBovine
GM-Tg-equg-IP2767-Ab-1/ GM-Tg-equg-IP2767-Ab-2Anti-Equine TEDC2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2767-Ab-1/ GM-Tg-hg-IP2767-Ab-2; GM-Tg-rg-IP2767-Ab-1/ GM-Tg-rg-IP2767-Ab-2;
GM-Tg-mg-IP2767-Ab-1/ GM-Tg-mg-IP2767-Ab-2; GM-Tg-cynog-IP2767-Ab-1/ GM-Tg-cynog-IP2767-Ab-2;
GM-Tg-felg-IP2767-Ab-1/ GM-Tg-felg-IP2767-Ab-2; GM-Tg-cang-IP2767-Ab-1/ GM-Tg-cang-IP2767-Ab-2;
GM-Tg-bovg-IP2767-Ab-1/ GM-Tg-bovg-IP2767-Ab-2; GM-Tg-equg-IP2767-Ab-1/ GM-Tg-equg-IP2767-Ab-2
Products NameAnti-TEDC2 monoclonal antibody
Formatmab
Target NameTEDC2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TEDC2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2767-Ag-1Recombinant multi-species TEDC2/ C16orf59 protein
    ORF Viral VectorpGMLV000059human TEDC2 Lentivirus plasmid
    ORF Viral VectorvGMLV000059human TEDC2 Lentivirus particle
    ORF Viral VectorpGMLV000546human TEDC2 Lentivirus plasmid
    ORF Viral VectorvGMLV000546human TEDC2 Lentivirus particle


    Target information

    Target IDGM-IP2767
    Target NameTEDC2
    Gene ID80178,72016,100158225,696863,610885,102901781,616898,100068393
    Gene Symbol and Synonyms1600002H07Rik,C13H16orf59,C16orf59,C20H16orf59,C25H16orf59,C6H16orf59,CE3H16orf59,TEDC2
    Uniprot AccessionQ7L2K0,Q3ZBU3
    Uniprot Entry NameTEDC2_HUMAN,TEDC2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000162062
    Target ClassificationN/A

    The target: TEDC2, gene name: TEDC2, also named as C16orf59. Predicted to be involved in positive regulation of smoothened signaling pathway. Predicted to be located in centriole and cilium. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.